Logistics & IT
The “Logistics & IT” segment comprises the two sectors “Wholesale” and “Logistics & IT Services”. They operate and develop the logistics and IT platforms of the Galenica Group and offer services to all healthcare providers such as pharmacies, drugstores, physicians, hospitals and care homes. The focus is on optimising and further developing the range of logistics and services as well as innovative solutions to promote digitalisation in the healthcare market.
“Logistics & IT” segment development
The “Logistics & IT” segment generated net sales of CHF 1,649.7 million (+5.5%) in the first half of 2025. Of this, CHF 1,579.6 million (+5.6%) was attributable to “Wholesale” and CHF 83.0 million (+6.9%) to “Logistics & IT Services”. As a result, the segment performed better than the overall market, which recorded strong year-on-year growth of 4.8% (IQVIA, Pharmaceutical Market Switzerland, first half of 2025).
Adjusted1 EBIT improved by +25.8% year-on-year to CHF 32.0 million in the first half of 2025. Return on sales (ROS) increased from 1.6% to 1.9%. In addition to the increase in sales, the improved EBIT performance was mainly due to positive one-time effects totalling CHF 5.4 million. Disregarding these one-time effects, adjusted1 EBIT would have increased by 4.6% to CHF 26.6 million and return on sales (ROS) would have remained stable at 1.6%.
The positive one-time effects result from two sets of proceedings at the Swiss Competition Commission (COMCO). On the one hand, the Federal Supreme Court issued its ruling in January 2025 in the proceedings initiated by COMCO concerning HCI Solutions in 2017, which should significantly reduce the penalty originally imposed (the penalty will be reassessed by the Federal Administrative Court). In addition, in the “Markant centralised processing” case, the penalty imposed by COMCO was significantly lower than originally expected.
Both factors had a positive impact on the segment’s EBIT. By contrast, temporary efficiency losses and additional expenses in connection with the gradual introduction of the new ERP system at the Lausanne-Ecublens site had a negative impact on the operating result in the “Wholesale & Logistics” segment.
1) Excluding the effects of IFRS 16. See chapter "Alternative performance measures"
Wholesale
In the “Wholesale” sector, sales increased by +5.6% to CHF 1,579.6 million, while further market shares were gained in the wholesale business with both doctors (+5.8%) and pharmacies (+5.6%).
By way of comparison, the market for doctors recorded growth of 4.4%, while the market for bricks-and-mortar pharmacies increased by 5.2%. The market for mail-order pharmacies grew by 4.7% in the reporting period (IQVIA, Pharmaceutical Market Switzerland, first half of 2025).
New ERP system in use
In March 2025, the important migration of the ERP system at the Lausanne-Ecublens site was completed. The focus in the second half of the year will now be on continuously increasing efficiency and ensuring that customers in French-speaking Switzerland are fully supplied from the Lausanne-Ecublens site.
Great momentum in the physician market
Since the 2024 financial year, the Galexis range for physicians has also included laboratory equipment, accessories and furnishings. In the first half of 2025, the company ramped up its marketing of the expanded range. The response has been very positive. The wider distribution of the DispoCura interface software, which makes the ordering process for doctors particularly user-friendly, also helps to position Galexis as an innovative wholesaler for physicians.
Logistics & IT Services
With net sales of CHF 83.0 million, the “Logistics & IT Services” sector achieved growth of 6.9% in the first half of 2025. In addition to HCI Solutions, this growth was driven in particular by intra-Group charging of IT services.
Health Supply transport services in operation
The joint venture Health Supply Ltd., founded at the end of 2023, replaced all external transport service providers as planned in the first half of 2025. Furthermore, in June 2025, the employees of the Spreitenbach site were integrated into the Regensdorf site. The joint venture has clear advantages in terms of efficiency for Galenica: Thanks to Health Supply, the Group obtains the majority of its transport services from a single provider, reducing complexity and coordination efforts. With its fleet, it can also implement sustainability initiatives such as the use of biogas or electric vehicles. The joint venture’s transport services are also available to other market participants.
Alloga well on track
Pre-wholesale specialist Alloga has significantly increased its efficiency and gained an important new industry partner following the completion of its ERP roll-out in 2024.
Digitalisation of healthcare
Developing and implementing initiatives for the digitalisation of healthcare is the core area of expertise of HCI Solutions, which also includes the medical and pharmacy software Documedis. Based on Documedis solutions, more than 240 million “Clinical Decision Support" (CDS) checks were performed in the first half of 2025; more and more software manufacturers are integrating the functionality from HCI Solutions into their systems. CDS checks are important measures for reviewing clinical medical decisions and increasing patient safety. The successful HCI Connect series of events, which facilitates networking between specialists and digitalisation experts, continued with an event in March 2025. The experts from HCI Solutions also presented new AI-supported features.
Increasing number of e-prescriptions
The two professional associations, the Swiss Medical Association (FMH) and pharmaSuisse, are continuing to drive forward with the nationwide introduction of e-prescriptions. HCI Solutions remained involved in the development during the reporting period as a private-sector expert partner. The commitment of all those involved is bearing fruit, with the number of e-prescriptions issued via Documedis already reaching around 6,000 per month.
Anniversary at Aquantic
Another company with an innovative software solution performed well in the first half of 2025: Aquantic. Its SmartMIP software enables the billing of specific medications to be processed quickly, in a standardised manner and in compliance with the law. These are primarily medications within the meaning of Article 71 a-d of the Health Insurance Ordinance (HIO) for the treatment of rare, very serious or chronic diseases. Aquantic Ltd. was acquired by Galenica in 2022 and is used by a growing number of health insurers and pharma companies. The company is already celebrating its 20th anniversary in 2025.